Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  American Journal of Medicine

• Publication date

  1987-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(87)90944-2PMID 3503575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

  1986cited by this paper
• Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD.

  1986cited by this paper
• MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.

  1985cited by this paper
• Stage IV diffuse large-cell lymphoma: a long-term analysis.

  1985cited by this paper
• Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

  1984cited by this paper
• Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.

  1984cited by this paper
• "Bad risk" non-Hodgkin lymphomas.

  1983cited by this paper
• Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

  1983cited by this paper
• Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

  1983cited by this paper
• Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variables

  1982cited by this paper
• Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

  1982cited by this paper
• Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma.

  1981cited by this paper
• Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).

  1977cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Sequential Nonsurgical and Surgical Staging of Non-Hodgkin's Lymphoma

  1976cited by this paper
• Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma.

  1976cited by this paper
• [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].

  1975cited by this paper
• Non-Hodgkin lymphomas.

  1975cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Anti-CD19 CAR-T cell therapy in elderly patients: multicentric real-world experience from GETH-TC/GELTAMO.

  2024cites this paper
• Diffuse Large B-Cell Lymphomas in Older Adults

  2020cites this paper
• Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

  2015cites this paper
• Diagnosis and Treatment of Non-Hodgkin’s Lymphoma of Adults

  2013cites this paper
• Biological and clinical features of non-Hodgkin's lymphoma in the elderly.

  2012cites this paper
• Diffuse large B-cell lymphoma in the older.

  2011cites this paper
• randomized trial of PAdriaCEBO versus PMitCEBO patients older than 60 with high-grade lymphoma: results of a BNLI Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for

  2008cites this paper
• Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology

  2008cites this paper
• Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.

  2007cites this paper
• Non-Hodgkin's lymphoma in patients 80 years of age or older.

  2006cites this paper
• A population‐based study of severity of comorbidity among patients with non‐Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index

  2005cites this paper
• The Treatment of Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma

  2005cites this paper
• Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.

  2005cites this paper
• European experiences on aggressive non-Hodgkin's lymphoma in elderly patients.

  2004cites this paper
• CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.

  2003cites this paper
• Non‐Hodgkin lymphoma in elderly patients

  2003cites this paper
• ACOD, a Modified CHOP Regimen for Elderly Patients with Aggressive Non-Hodgkin's Lymphoma

  2003cites this paper
• Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen

  2003cites this paper
• First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.

  2003cites this paper
• Treatment results of aggressive B non‐Hodgkin's lymphoma in advanced age considering comorbidity

  2002cites this paper
• Aggressive Non-Hodgkin’s Lymphoma Treated at the Institute of Oncology, Istanbul: Treatment, Outcome, and Prognostic Factors

  2002cites this paper
• Non-Hodgkin's lymphoma in patients 70 years of age or older: factors associated with survival.

  2002cites this paper
• Continuous Infusion of Vincristine-Doxorubicin with Bolus of Dexamethasone(VAD) Alternated with CHEP in the Treatment of Patients over 60 Years Old with Aggressive Non-Hodgkin's Lymphoma

  2001cites this paper
• Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study

  2001cites this paper
• The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).

  2001cites this paper
• Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

  2001cites this paper
• [Mistletoe extracts in the therapy of malignant, hematological and lymphatic diseases--a monocentric, retrospective analysis over 16 years].

  2000cites this paper
• The management of adult aggressive non-Hodgkin's lymphomas.

  2000cites this paper
• Autologous blood and marrow transplantation in patients 60 years and older.

  2000cites this paper
• VECP-Bleo regimen as treatment of advanced stage aggressive non-Hodgkin’s Lymphoma in elderly patients a GOELAMS protocol

  2000cites this paper
• Granulocyte-Colony Stimulating Factor (G-CSF) May Improve Disease Outcome in Elderly Patients with Diffuse Large Cell Lymphoma (DLCL) Treated with CHOP Chemotherapy

  2000cites this paper
• Non-Hodgkin’s Lymphoma in the Elderly

  1999cites this paper
• High-grade non-Hodgkin's lymphoma treated in northern Norway--treatment, outcome, and prognostic factors.

  1999cites this paper
• Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993–1996

  1999cites this paper
• Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma--possible pitfalls in results reporting and interpretation.

  1999cites this paper
• Intermediate and high grade non Hodgkin's lymphoma in the elderly.

  1999cites this paper
• Two Oral Trofosfamide Schedules in Elderly Patients with Refractory Non-Hodgkin‘s Lymphoma

  1999cites this paper
• Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996

  1999cites this paper
• CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

  1998cites this paper
• [Long term results of treatment of highly-malignant non-Hodgkin lymphoma in the elderly (70 years and older)].

  1998cites this paper
• Prognosis and Management Strategies of Lymphatic Neoplasias in the Elderly

  1998cites this paper
• Prognosis and Management Strategies of Lymphatic Neoplasias in the Elderly

  1998cites this paper
• Chemotherapy in the elderly.

  1998cites this paper
• Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study

  1998cites this paper
• Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.

  1998cites this paper
• Treatment of non‐Hodgkin's lymphoma in the elderly: an update

  1998cites this paper
• Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.

  1998cites this paper
• Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy.

  1997cites this paper
• Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project.

  1997cites this paper
• Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age

  1997cites this paper
• Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

  1997cites this paper
• High-grade non-Hodgkin's lymphoma stage I. A retrospective study of treatment, outcome and prognostic factors in 213 patients.

  1996cites this paper
• Non-Hodgkin's Lymphoma in the Elderly.

  1996cites this paper
• Can prognostic factors be applied in treatment selection for aggressive lymphoma patients?

  1996cites this paper
• The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.

  1996cites this paper
• Autologous bone marrrow transplantation versus chemotherapy in relapsed/refractory non‐hodgkin's lymphoma: Estimates of long‐term survival from the recent literatur

  1995cites this paper
• High grade non‐Hodgkins lymphoma in the elderly—12 year experience in the grampian region of scotland

  1995cites this paper
• Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients.

  1995cites this paper
• [Treatment of intermediate-grade non-Hodgkin lymphoma in adults].

  1995cites this paper
• Prognostic Factors in Aggressive Non-Hodgkin’s Lymphoma

  1995cites this paper
• Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.

  1995cites this paper
• Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

  1995cites this paper
• Traitement des lymphomes non hodgkiniens de malignité intermédiaire de l'adulte

  1995cites this paper
• Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma.

  1995cites this paper
• Lymphoma in the older patient.

  1995cites this paper
• Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

  1995cites this paper
• Autologous bone marrow transplantation versus chemotherapy in relapsed/refractory non-Hodgkin's lymphoma: estimates of long-term survival from the recent literature.

  1995cites this paper
• Mitoxantrone, chlorambucil and prednisolone in the treatment of non-Hodgkin's lymphoma.

  1994cites this paper
• P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).

  1994cites this paper
• Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.

  1994cites this paper
• Prednisone, oral etoposide, and novantrone for treatment of non-Hodgkin's lymphoma: a preliminary report.

  1994cites this paper
• Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

  1994cites this paper
• Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin's lymphoma: a prospective study in 52 patients.

  1994cites this paper
• Aggressive non-Hodgkin's lymphoma in the elderly: an effective, well-tolerated treatment regimen containing extended-schedule etoposide.

  1994cites this paper
• Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR).

  1994cites this paper
• Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens.

  1994cites this paper
• Non-Hodgkin's lymphoma in northern Sweden. Prognostic factors and response to treatment.

  1993cites this paper
• Cancer in the elderly.

  1993cites this paper
• Non‐Hodgkin's Lymphoma in the Older Person: A Review

  1993cites this paper
• Non-Hodgkin's lymphomas in elderly patients.

  1993cites this paper
• P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.

  1993cites this paper
• What is the role of third generation regimens for initial therapy of non-Hodgkin's lymphomas?

  1993cites this paper
• Chronological age is a multifactorial prognostic variable in patients with non-Hodgkin's lymphoma.

  1992cites this paper
• A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.

  1992cites this paper
• Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).

  1991cites this paper
• A brief‐duration combination chemotherapy for elderly patients with poor‐prognosis non‐Hodgkin's lymphoma

  1991cites this paper
• The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma.

  1991cites this paper
• Treatment of low‐grade and intermediate‐grade lymphoma with intensive combination chemotherapy results in long‐term, disease‐free survival

  1990cites this paper
• Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment.

  1990cites this paper
• Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.

  1990cites this paper
• [Treatment of aggressive non-Hodgkin's lymphoma in aged patients with a combination of methyl-GAG, etoposide and prednimustine].

  1990cites this paper
• Non‐Hodgkin's lymphomas: Recent concepts in classification and treatment

  1989cites this paper
• Flexible regression models with cubic splines.

  1989cites this paper
• Therapy for lymphoma in the elderly.

  1989cites this paper
• The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

  1988cites this paper
• SchluÈ sselwoÈ rter

  year unknowncites this paper